Relaxation of restrictions coincided with increasing incidence of COVID-19, non-COVID-19 ARI, severe asthma exacerbations
Monkeypox Renamed Mpox Amid Racism Concerns
Virus has been called monkeypox since 1958, when it was first observed in Denmark in research monkeys
New COVID-19 Variant XBB Gaining Ground Among Americans
New omicron subvariant is taking hold in the United States, health officials say, though it does not look more severe than its predecessors
The Recreational Potential Index Influences Behaviors
Since the recent pandemic limited a person's mobility and social life, people's recreational behavior made them seek more contact with nature closer to home.
As a result, locating recreational spaces in the vicinity of cities gained importance.
A new Scientific Reports study proposed a methodology for assessing the tourist and recreational potential of areas (METPRET) in the vicinity of cities with the potential to meet the needs for tourism and recreation.
Millions of Children Susceptible to Measles
The World Health Organization (WHO) recently reported about forty million children are currently susceptible to the growing measles risk.
On November 23, 2022, the WHO announced a record twenty-five million children missed their first measle vaccine dose, and an additional 14.7 million children missed their second dose.
This decline is a significant setback in global progress toward achieving and maintaining measles elimination and leaves millions of children susceptible to infection, stated the WHO.
Fentanyl Vaccine Candidate Could Change Opioid Epidemic
A pre-clinical vaccine candidate targeting the dangerous synthetic opioid fentanyl (FEN) was recently found to block its ability to enter the brain, thus eliminating the drug's "high."
The breakthrough discovery by researchers led by the University of Houston could have significant implications for the nation's opioid epidemic by becoming a relapse prevention agent for people trying to quit using opioids.
While research reveals Opioid Use Disorder (OUD) is treatable, an estimated 80% of those dependent on the drug suffer a relapse.
New Dengue Vaccine Resolves Old Dilemma
One of the worlds leading mosquito-borne viruses has increased globally over the past two decades and is endemic in more than 125 countries.
The good news is dengue has had a U.S. Food and Drug Administration (FDA) approved vaccine available for a few years.
However, deploying the Dengvaxia vaccine comes with very specific requirements to prevent dengue infections.
Dengue is caused by any of four dengue virus serotypes, each of which can cause dengue fever or severe dengue.
Monkeypox Vaccine Efficacy Disclosed
The most robust clinical evidence for the effectiveness of the monkeypox virus (MPX) vaccine was published today by the U.K. Health Security Agency (UKHSA).
The UKHSA estimates that the two-dose JYNNEOS® (MVA-BN, IMVAMUNE®) vaccine effectiveness for a single dose was 78% fourteen or more days after the initial vaccination.
Monkeypox Outbreak Recedes in the U.K.
The U.K. Health Security Agency (UKHSA) confirmed today the epidemiological situation of the monkeypox virus outbreak.
Cases of monkeypox (MPX) infection have been confirmed in England since May 6, 2022.
As of November 21, 2022, there were 3,570 confirmed and 150 highly probable monkeypox cases detected in the U.K.
Of these, 96 were in Scotland, 34 were in Northern Ireland, 47 were in Wales, and 3,543 (69%) were in England.
There are no reported deaths in the U.K.
Double Facial Recognition Launches in Real-Time
As the U.S. Transportation Security Administration (TSA) continues deploying innovative technologies in Digital ID, air travelers are enjoying safer and more effortless screening experiences.
For example, catching a flight at Denver's international airport (DEN) requires a new, real-time photo comparison of the traveler.
The TSA recently announced the next generation of Credential Authentication Technology (CAT) verifies the traveler's photo on the credential against the in-person, real-time image.